B cell or plasma cell-produced NMO-IgG binding to astrocytic AQP4 activates complement deposition [48–50], leading to astrocyte damage and inflammatory reaction [51] with leukocyte infiltration [50] and cytokine release [52], thus resulting in disease development. This evidence concerns the gene AQP4 and neuromyelitis optica.